Financhill
Sell
45

ACON Quote, Financials, Valuation and Earnings

Last price:
$7.18
Seasonality move :
-26.2%
Day range:
$7.06 - $7.47
52-week range:
$6.20 - $3,499.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.47x
P/B ratio:
0.27x
Volume:
14K
Avg. volume:
15.6K
1-year change:
-99.73%
Market cap:
$4.3M
Revenue:
$45.7K
EPS (TTM):
-$4,219.12

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ACON
Aclarion
$30K -$2.26 173.45% -99.83% $20.00
DRIO
DarioHealth
$6.9M -$0.10 15.09% -74.67% $2.38
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$2.4M -- -13% -- $3.00
SPOK
Spok Holdings
$35M $0.24 3% 18.18% $20.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ACON
Aclarion
$7.33 $20.00 $4.3M -- $0.00 0% 7.47x
DRIO
DarioHealth
$0.70 $2.38 $31.1M -- $0.00 0% 1.04x
FOXO
FOXO Technologies
$0.15 -- $958.4K -- $0.00 0% 0.04x
OTRK
Ontrak
$0.49 $3.00 $2.1M -- $0.00 0% 0.24x
SPOK
Spok Holdings
$17.70 $20.00 $364.1M 22.69x $0.31 7.06% 2.62x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ACON
Aclarion
-- 5.415 -- 21.13x
DRIO
DarioHealth
28.37% -0.588 111.66% 1.76x
FOXO
FOXO Technologies
38.2% 9.895 144.44% 0.09x
OTRK
Ontrak
67.21% -1.433 155.76% 0.50x
SPOK
Spok Holdings
-- 1.151 -- 0.99x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ACON
Aclarion
-$4.5K -$1.5M -133.4% -141.65% -10728.43% -$2.6M
DRIO
DarioHealth
$3.9M -$9.4M -45.31% -63.94% -139.35% -$6.7M
FOXO
FOXO Technologies
$1.3M -$1.5M -214.25% -- 8.49% -$1.3M
OTRK
Ontrak
$746K -$5.9M -144.37% -222.91% -290.04% -$2.8M
SPOK
Spok Holdings
$29.1M $6.1M 10.19% 10.19% 16.74% $1.5M

Aclarion vs. Competitors

  • Which has Higher Returns ACON or DRIO?

    DarioHealth has a net margin of -10728.43% compared to Aclarion's net margin of -136.66%. Aclarion's return on equity of -141.65% beat DarioHealth's return on equity of -63.94%.

    Company Gross Margin Earnings Per Share Invested Capital
    ACON
    Aclarion
    -23.63% -$9.32 $15.8M
    DRIO
    DarioHealth
    57.49% -$0.14 $102.9M
  • What do Analysts Say About ACON or DRIO?

    Aclarion has a consensus price target of $20.00, signalling upside risk potential of 172.85%. On the other hand DarioHealth has an analysts' consensus of $2.38 which suggests that it could grow by 239.29%. Given that DarioHealth has higher upside potential than Aclarion, analysts believe DarioHealth is more attractive than Aclarion.

    Company Buy Ratings Hold Ratings Sell Ratings
    ACON
    Aclarion
    1 0 0
    DRIO
    DarioHealth
    3 1 0
  • Is ACON or DRIO More Risky?

    Aclarion has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.551, suggesting its more volatile than the S&P 500 by 55.126%.

  • Which is a Better Dividend Stock ACON or DRIO?

    Aclarion has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aclarion pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ACON or DRIO?

    Aclarion quarterly revenues are $19K, which are smaller than DarioHealth quarterly revenues of $6.8M. Aclarion's net income of -$2M is higher than DarioHealth's net income of -$9.2M. Notably, Aclarion's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aclarion is 7.47x versus 1.04x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ACON
    Aclarion
    7.47x -- $19K -$2M
    DRIO
    DarioHealth
    1.04x -- $6.8M -$9.2M
  • Which has Higher Returns ACON or FOXO?

    FOXO Technologies has a net margin of -10728.43% compared to Aclarion's net margin of -19.45%. Aclarion's return on equity of -141.65% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    ACON
    Aclarion
    -23.63% -$9.32 $15.8M
    FOXO
    FOXO Technologies
    39.94% -$0.37 $15.7M
  • What do Analysts Say About ACON or FOXO?

    Aclarion has a consensus price target of $20.00, signalling upside risk potential of 172.85%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that Aclarion has higher upside potential than FOXO Technologies, analysts believe Aclarion is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    ACON
    Aclarion
    1 0 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is ACON or FOXO More Risky?

    Aclarion has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ACON or FOXO?

    Aclarion has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aclarion pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ACON or FOXO?

    Aclarion quarterly revenues are $19K, which are smaller than FOXO Technologies quarterly revenues of $3.2M. Aclarion's net income of -$2M is lower than FOXO Technologies's net income of -$616.5K. Notably, Aclarion's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aclarion is 7.47x versus 0.04x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ACON
    Aclarion
    7.47x -- $19K -$2M
    FOXO
    FOXO Technologies
    0.04x -- $3.2M -$616.5K
  • Which has Higher Returns ACON or OTRK?

    Ontrak has a net margin of -10728.43% compared to Aclarion's net margin of -341.65%. Aclarion's return on equity of -141.65% beat Ontrak's return on equity of -222.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    ACON
    Aclarion
    -23.63% -$9.32 $15.8M
    OTRK
    Ontrak
    36.99% -$1.65 $14.2M
  • What do Analysts Say About ACON or OTRK?

    Aclarion has a consensus price target of $20.00, signalling upside risk potential of 172.85%. On the other hand Ontrak has an analysts' consensus of $3.00 which suggests that it could grow by 516.02%. Given that Ontrak has higher upside potential than Aclarion, analysts believe Ontrak is more attractive than Aclarion.

    Company Buy Ratings Hold Ratings Sell Ratings
    ACON
    Aclarion
    1 0 0
    OTRK
    Ontrak
    1 0 0
  • Is ACON or OTRK More Risky?

    Aclarion has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.163, suggesting its more volatile than the S&P 500 by 116.314%.

  • Which is a Better Dividend Stock ACON or OTRK?

    Aclarion has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Aclarion pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ACON or OTRK?

    Aclarion quarterly revenues are $19K, which are smaller than Ontrak quarterly revenues of $2M. Aclarion's net income of -$2M is higher than Ontrak's net income of -$6.9M. Notably, Aclarion's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aclarion is 7.47x versus 0.24x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ACON
    Aclarion
    7.47x -- $19K -$2M
    OTRK
    Ontrak
    0.24x -- $2M -$6.9M
  • Which has Higher Returns ACON or SPOK?

    Spok Holdings has a net margin of -10728.43% compared to Aclarion's net margin of 14.32%. Aclarion's return on equity of -141.65% beat Spok Holdings's return on equity of 10.19%.

    Company Gross Margin Earnings Per Share Invested Capital
    ACON
    Aclarion
    -23.63% -$9.32 $15.8M
    SPOK
    Spok Holdings
    80.13% $0.25 $151.7M
  • What do Analysts Say About ACON or SPOK?

    Aclarion has a consensus price target of $20.00, signalling upside risk potential of 172.85%. On the other hand Spok Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 12.99%. Given that Aclarion has higher upside potential than Spok Holdings, analysts believe Aclarion is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ACON
    Aclarion
    1 0 0
    SPOK
    Spok Holdings
    1 0 0
  • Is ACON or SPOK More Risky?

    Aclarion has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.582, suggesting its less volatile than the S&P 500 by 41.788%.

  • Which is a Better Dividend Stock ACON or SPOK?

    Aclarion has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.06% to investors and pays a quarterly dividend of $0.31 per share. Aclarion pays -- of its earnings as a dividend. Spok Holdings pays out 176.29% of its earnings as a dividend.

  • Which has Better Financial Ratios ACON or SPOK?

    Aclarion quarterly revenues are $19K, which are smaller than Spok Holdings quarterly revenues of $36.3M. Aclarion's net income of -$2M is lower than Spok Holdings's net income of $5.2M. Notably, Aclarion's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 22.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Aclarion is 7.47x versus 2.62x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ACON
    Aclarion
    7.47x -- $19K -$2M
    SPOK
    Spok Holdings
    2.62x 22.69x $36.3M $5.2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Oklo Stock Double?
Will Oklo Stock Double?

Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…

Why a $5 Stock Is Suddenly a Cash Machine
Why a $5 Stock Is Suddenly a Cash Machine

If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…

Is Roku Stock Undervalued Now?
Is Roku Stock Undervalued Now?

At roughly $89 a share, Roku (NASDAQ: ROKU) trades for barely…

Stock Ideas

Buy
69
Is NVDA Stock a Buy?

Market Cap: $4T
P/E Ratio: 56x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 43x

Sell
42
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
77
VBTX alert for Jul 15

Veritex Holdings [VBTX] is down 0.52% over the past day.

Buy
72
MNPR alert for Jul 15

Monopar Therapeutics [MNPR] is up 0.02% over the past day.

Buy
56
NBIS alert for Jul 15

Nebius Group NV [NBIS] is up 5.68% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock